Title : Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial.

Pub. Date : 2019 Aug 1

PMID : 30985556






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Switching to Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate (DOR/3TC/TDF) Maintains HIV-1 Virologic Suppression Through 48 Weeks: Results of the DRIVE-SHIFT Trial. Tenofovir sex determining region Y Homo sapiens